Technology | 2020.01.07
Debut Biotechnology Closes $2.6M Seed Round to Bring Continuous Biomanufacturing of High-Value Molecules to Pharma
Debut Bio’s easy-to-use enzyme cartridges enable sustainable manufacturing of complex pharmaceuticals in an automated, continuous manufacturing system
(PRWeb January 07, 2020)
Read the full story at https://www.prweb.com/releases/debut_biotechnology_closes_2_6m_seed_round_to_bring_continuous_biomanufacturing_of_high_value_molecules_to_pharma/prweb16817991.htm
For more information, please visit
https://www.prweb.com/releases/debut_bio[...]es_to_pharma/prweb16817991.htm
